EUVIMEDEUVIMED entdecken
Open Access

Novel Antibiotics and Emerging Resistance: In Vitro Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital

Hüseyin Haydar Kutlu iD, Fatma Nur Akdoğan-Kittana iD, Betül Günaydın iD, Yekta Özkılıç iD

Infectious Diseases and Clinical Microbiology · 30.03.2026 · 179

DOI: 10.36519/idcm.2026.896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases and Clinical Microbiology, online erschienen am 30.03.2026. Verfasst von Hüseyin Haydar Kutlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Uşak University Faculty of Medicine, Uşak, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: The global spread of antibiotic resistance, particularly in carbapenem-resistant Gram-negative bacteria, has become a major public health concern. Recently developed antibiotics—ceftazidime-avibactam (CAZ-AVI), ceftolozane-tazobactam (TOL-TAZ), meropenem-vaborbactam (MER-VAB), eravacycline (ERV), and delafloxacin (DLX)—represent promising therapeutic alternatives. This study aimed to assess resistance patterns to these novel agents among Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates from intensive care units (ICUs). Materials and Methods: Between January 2023 and December 2024, isolates obtained from ICU cultures at Uşak Training and Research Hospital were analyzed. Species identification was performed using the VITEK® 2 and VITEK® MS systems (bioMérieux, Marcy-l’Étoile, France). Antimicrobial susceptibility testing was conducted with the VITEK® 2 AST XN21 card (bioMérieux, Marcy-l’Étoile, France), while colistin (COL) susceptibility was determined by broth microdilution. Results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines, and statistical analysis was performed using Pearson’s chi-square test (p

Schlagwörter

Stichwörter der Autor:innen

Antibiotic resistanceceftazidime-avibactamceftolozane-tazobactamdelafloxacineravacyclinemeropenem-vaborbactam

Autor:innen und Institutionen

  • Department of Medical Microbiology, Uşak University Faculty of Medicine, Uşak, Türkiye.
  • Medical Microbiology Laboratory, Uşak Training and Research Hospital, Uşak, Türkiye.
  • Department of Infectious Diseases and Clinical Microbiology, Uşak Training and Research Hospital, Uşak, Türkiye.

ORCID-Profile: Hüseyin Haydar Kutlu, Fatma Nur Akdoğan-Kittana, Betül Günaydın, Yekta Özkılıç

Zitieren

APA

Kutlu, H. H., Akdoğan-Kittana, F. N., Günaydın, B., & Özkılıç, Y. (2026). Novel Antibiotics and Emerging Resistance: In Vitro Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital. Infectious Diseases and Clinical Microbiology, 179. https://doi.org/10.36519/idcm.2026.896

Vancouver

Kutlu HH, Akdoğan-Kittana FN, Günaydın B, Özkılıç Y. Novel Antibiotics and Emerging Resistance: In Vitro Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital. Infectious Diseases and Clinical Microbiology. 2026:179. doi:10.36519/idcm.2026.896

BibTeX
@article{Kutlu2026,
  author = {Kutlu, Hüseyin Haydar and Akdoğan-Kittana, Fatma Nur and Günaydın, Betül and Özkılıç, Yekta},
  title = {Novel Antibiotics and Emerging Resistance: In Vitro Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital},
  journal = {Infectious Diseases and Clinical Microbiology},
  year = {2026},
  pages = {179},
  doi = {10.36519/idcm.2026.896}
}
Kostenlos starten →